Choroidal Neovascularization Market 2027 By Route of Administration | The Insight Partners

Choroidal Neovascularization Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Route of Administration (Intravenous, Intravitreal)

Report Code: TIPRE00016865 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Neovascularization refers to the term new blood vessels. Choroidal neovascularization is abnormal condition where, new blood vessels originates from choroid, a layer situated under the retina. The occurrence of this condition is majorly observed in patients with AMD (Age-related Macular Degeneration). Vision distortion is one of the prominent symptom of CNV (Choroidal Neovascularization).

MARKET DYNAMICS

The choroidal neovascularization market is expected to witness considerable growth due to rise in geriatric population. Moreover, increasing research in drug development for the treatment of choroidal neovascularization is also expected to drive the market growth. However, lack of awareness amongst general populations, especially in emerging countries is estimated to hamper the growth of the global choroidal neovascularization market.

MARKET SCOPE

The "Choroidal Neovascularization Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Choroidal Neovascularization Market with detailed market segmentation by route of administration. The Choroidal Neovascularization Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Choroidal Neovascularization Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Choroidal Neovascularization Market is segmented on the basis of route of administration. Based on route of administration, the market is segmented as intravenous and intravitreal.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Choroidal Neovascularization Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Choroidal Neovascularization Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Choroidal Neovascularization Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Choroidal Neovascularization Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Choroidal Neovascularization Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Choroidal Neovascularization Market are anticipated to have lucrative growth opportunities in the future with the rising demand for smart hospital beds in the global market. Below mentioned is the list of few companies engaged in the Choroidal Neovascularization Market.

The report also includes the profiles of key players in Choroidal Neovascularization Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Affitech A/S
  •  F. Hoffmann-La Roche Ltd.
  •  Lpath, Inc.
  •  Mat Biopharma
  •  Promedior, Inc.
  •  Regeneron Pharmaceuticals, Inc.
  •  Resolvyx Pharmaceuticals, Inc
  •  Sanwa Kagaku Kenkyusho Co., Ltd

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Choroidal Neovascularization Market - By Route of Administration
1.3.2 Choroidal Neovascularization Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CHOROIDAL NEOVASCULARIZATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CHOROIDAL NEOVASCULARIZATION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CHOROIDAL NEOVASCULARIZATION MARKET - GLOBAL MARKET ANALYSIS
6.1. CHOROIDAL NEOVASCULARIZATION - GLOBAL MARKET OVERVIEW
6.2. CHOROIDAL NEOVASCULARIZATION - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CHOROIDAL NEOVASCULARIZATION MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
7.1. OVERVIEW
7.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
7.3. INTRAVENOUS
7.3.1. Overview
7.3.2. Intravenous Market Forecast and Analysis
7.4. INTRAVITREAL
7.4.1. Overview
7.4.2. Intravitreal Market Forecast and Analysis
8. CHOROIDAL NEOVASCULARIZATION MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Choroidal Neovascularization Market Overview
8.1.2 North America Choroidal Neovascularization Market Forecasts and Analysis
8.1.3 North America Choroidal Neovascularization Market Forecasts and Analysis - By Route of Administration
8.1.4 North America Choroidal Neovascularization Market Forecasts and Analysis - By Countries
8.1.4.1 United States Choroidal Neovascularization Market
8.1.4.1.1 United States Choroidal Neovascularization Market by Route of Administration
8.1.4.2 Canada Choroidal Neovascularization Market
8.1.4.2.1 Canada Choroidal Neovascularization Market by Route of Administration
8.1.4.3 Mexico Choroidal Neovascularization Market
8.1.4.3.1 Mexico Choroidal Neovascularization Market by Route of Administration
8.2. EUROPE
8.2.1 Europe Choroidal Neovascularization Market Overview
8.2.2 Europe Choroidal Neovascularization Market Forecasts and Analysis
8.2.3 Europe Choroidal Neovascularization Market Forecasts and Analysis - By Route of Administration
8.2.4 Europe Choroidal Neovascularization Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Choroidal Neovascularization Market
8.2.4.1.1 Germany Choroidal Neovascularization Market by Route of Administration
8.2.4.2 France Choroidal Neovascularization Market
8.2.4.2.1 France Choroidal Neovascularization Market by Route of Administration
8.2.4.3 Italy Choroidal Neovascularization Market
8.2.4.3.1 Italy Choroidal Neovascularization Market by Route of Administration
8.2.4.4 Spain Choroidal Neovascularization Market
8.2.4.4.1 Spain Choroidal Neovascularization Market by Route of Administration
8.2.4.5 United Kingdom Choroidal Neovascularization Market
8.2.4.5.1 United Kingdom Choroidal Neovascularization Market by Route of Administration
8.2.4.6 Rest of Europe Choroidal Neovascularization Market
8.2.4.6.1 Rest of Europe Choroidal Neovascularization Market by Route of Administration
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Choroidal Neovascularization Market Overview
8.3.2 Asia-Pacific Choroidal Neovascularization Market Forecasts and Analysis
8.3.3 Asia-Pacific Choroidal Neovascularization Market Forecasts and Analysis - By Route of Administration
8.3.4 Asia-Pacific Choroidal Neovascularization Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Choroidal Neovascularization Market
8.3.4.1.1 Australia Choroidal Neovascularization Market by Route of Administration
8.3.4.2 China Choroidal Neovascularization Market
8.3.4.2.1 China Choroidal Neovascularization Market by Route of Administration
8.3.4.3 India Choroidal Neovascularization Market
8.3.4.3.1 India Choroidal Neovascularization Market by Route of Administration
8.3.4.4 Japan Choroidal Neovascularization Market
8.3.4.4.1 Japan Choroidal Neovascularization Market by Route of Administration
8.3.4.5 South Korea Choroidal Neovascularization Market
8.3.4.5.1 South Korea Choroidal Neovascularization Market by Route of Administration
8.3.4.6 Rest of Asia-Pacific Choroidal Neovascularization Market
8.3.4.6.1 Rest of Asia-Pacific Choroidal Neovascularization Market by Route of Administration
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Choroidal Neovascularization Market Overview
8.4.2 Middle East and Africa Choroidal Neovascularization Market Forecasts and Analysis
8.4.3 Middle East and Africa Choroidal Neovascularization Market Forecasts and Analysis - By Route of Administration
8.4.4 Middle East and Africa Choroidal Neovascularization Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Choroidal Neovascularization Market
8.4.4.1.1 South Africa Choroidal Neovascularization Market by Route of Administration
8.4.4.2 Saudi Arabia Choroidal Neovascularization Market
8.4.4.2.1 Saudi Arabia Choroidal Neovascularization Market by Route of Administration
8.4.4.3 U.A.E Choroidal Neovascularization Market
8.4.4.3.1 U.A.E Choroidal Neovascularization Market by Route of Administration
8.4.4.4 Rest of Middle East and Africa Choroidal Neovascularization Market
8.4.4.4.1 Rest of Middle East and Africa Choroidal Neovascularization Market by Route of Administration
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Choroidal Neovascularization Market Overview
8.5.2 South and Central America Choroidal Neovascularization Market Forecasts and Analysis
8.5.3 South and Central America Choroidal Neovascularization Market Forecasts and Analysis - By Route of Administration
8.5.4 South and Central America Choroidal Neovascularization Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Choroidal Neovascularization Market
8.5.4.1.1 Brazil Choroidal Neovascularization Market by Route of Administration
8.5.4.2 Argentina Choroidal Neovascularization Market
8.5.4.2.1 Argentina Choroidal Neovascularization Market by Route of Administration
8.5.4.3 Rest of South and Central America Choroidal Neovascularization Market
8.5.4.3.1 Rest of South and Central America Choroidal Neovascularization Market by Route of Administration
9. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CHOROIDAL NEOVASCULARIZATION MARKET
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Middle East and Africa
9.5 South and Central America
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. CHOROIDAL NEOVASCULARIZATION MARKET, KEY COMPANY PROFILES
11.1. AFFITECH A/S
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. F. HOFFMANN-LA ROCHE LTD.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. LPATH, INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. MAT BIOPHARMA
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. PROMEDIOR, INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. REGENERON PHARMACEUTICALS, INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. RESOLVYX PHARMACEUTICALS, INC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SANWA KAGAKU KENKYUSHO CO., LTD
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Affitech A/S
2. F. Hoffmann-La Roche Ltd.
3. Lpath, Inc.
4. Mat Biopharma
5. Promedior, Inc.
6. Regeneron Pharmaceuticals, Inc.
7. Resolvyx Pharmaceuticals, Inc
8. Sanwa Kagaku Kenkyusho Co., Ltd.
TIPRE00016865
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking